Zealand Pharma A/S
XBER:22Z
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Z
|
Zealand Pharma A/S
XBER:22Z
|
DK |
|
Z
|
Zealand Pharma A/S
SWB:22Z
|
DK |
|
Zealand Pharma A/S
CSE:ZEAL
|
DK |
Wall St Price Targets
22Z Price Targets Summary
Zealand Pharma A/S
According to Wall Street analysts, the average 1-year price target for 22Z is 119.45 EUR with a low forecast of 65.06 EUR and a high forecast of 204.03 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 22Z's stock price target?
Price Target
119.45
EUR
According to Wall Street analysts, the average 1-year price target for 22Z is 119.45 EUR with a low forecast of 65.06 EUR and a high forecast of 204.03 EUR.
What is the Revenue forecast for Zealand Pharma A/S?
Projected CAGR
-8%
Over the last 14 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is -8%.
What is the Operating Income forecast for Zealand Pharma A/S?
Projected CAGR
-20%
Over the last 14 years, the compound annual growth rate for Operating Income has been 61%. The projected CAGR for the next 8 years is -20%.
What is the Net Income forecast for Zealand Pharma A/S?
Projected CAGR
-29%
Over the last 14 years, the compound annual growth rate for Net Income has been 55%. The projected CAGR for the next 8 years is -29%.
